Skip to content

Comparison of the effect of low-dose amiodarone alone and its combination with ?magnesium in the control of atrial fibrillation after coronary artery bypass graft

Comparison of the effect of low-dose amiodarone alone and its combination with ?magnesium in the control of atrial fibrillation after coronary artery bypass graft

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N169
Enrollment
208
Registered
2021-11-06
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery bypass graft. Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris

Interventions

Intervention 1: Intervention group 1: 300 milligram of Amiodarone is placed on the syringe pump, which is infused for the patient in 20 minutes, and 2 grams of magnesium sulfate will be slowly injecte

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients are candidates for coronary artery bypass graft surgery Their surgery is ON Pump Absence of emergency coronary artery bypass graft surgery Lack of valve repair and replacement surgery Insensitivity to Amiodarone and Magnesium

Exclusion criteria

Exclusion criteria: Patients who suffer from cardio-respiratory arrest during surgery and die during surgery. Patients who go to the cardiopulmonary pump more than once for any reason.

Design outcomes

Primary

MeasureTime frame
Duration of hospitalization in the intensive care unit. Timepoint: In duration study. Method of measurement: Patient file.;Incidence of atrial fibrillation. Timepoint: From the beginning of the intervention until 72 hours after the operation. Method of measurement: Physical examination.;Mortality rate. Timepoint: During the study. Method of measurement: Patient file.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Rostami

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026